Dr. Nancy A. Collop, M.D.
Sleep Medicine (Sleep Medicine (Internal Medicine) Physician)
- Medicare participating
At a glance
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 230
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Sleep Medicine (Internal Medicine) Physician primary
GA license 65096 -
Pulmonary Disease Physician
GA license 65096
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 230
- Services billed
- 350
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 121 | 109 |
| Established patient office or other outpatient visit, 30-39 minutes | 88 | 76 |
| Sleep study including heart rate, breathing, and sleep time | 37 | 36 |
| Sleep study in sleep lab (6 years or older) | 30 | 30 |
| Established patient office or other outpatient visit, 40-54 minutes | 17 | 16 |
| New patient office or other outpatient visit, 45-59 minutes | 16 | 16 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Atlanta, GA | 30 |
| Pregabalin Other prescribers in Atlanta, GA | 28 |
| Clonazepam Other prescribers in Atlanta, GA | 23 |
| Zolpidem Tartrate Other prescribers in Atlanta, GA | 23 |
| Methadone Hcl Other prescribers in Atlanta, GA | 19 |
| Pramipexole Dihydrochloride (pramipexole di-hcl) Other prescribers in Atlanta, GA | 18 |
| Ropinirole Hcl Other prescribers in Atlanta, GA | 17 |
| Sunosi (solriamfetol hcl) | 13 |
| Sodium Oxybate | 12 |
| Xywav (sodium,calcium,mag,pot oxybate) | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 15 payments worth $20,271 in total to this clinician.
| Zoll Respicardia, Inc. | $20,271 |
|---|
| Speaking at a medical education program | $13,500 |
|---|---|
| Consulting Fee | $3,300 |
| Travel and Lodging | $2,053 |
| Food and Beverage | $1,418 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Zoll Respicardia, Inc. May 3, 2025 | Speaking at a medical education program remede System · Respiratory | $4,500 |
| Zoll Respicardia, Inc. Oct 1, 2025 | Consulting Fee remede System · Respiratory | $3,000 |
| Zoll Respicardia, Inc. Jun 9, 2025 | Speaking at a medical education program remede System · Respiratory | $3,000 |
| Zoll Respicardia, Inc. Oct 20, 2025 | Speaking at a medical education program remede System · Respiratory | $3,000 |
| Zoll Respicardia, Inc. Nov 14, 2025 | Speaking at a medical education program remede System · Respiratory | $3,000 |
| Zoll Respicardia, Inc. May 1, 2025 | Travel and Lodging remede System · Respiratory · travel to Minneapolis, MN | $992 |
| Zoll Respicardia, Inc. Nov 14, 2025 | Travel and Lodging remede System · Respiratory · travel to Dallas, TX | $883 |
| Zoll Respicardia, Inc. Oct 20, 2025 | Consulting Fee remede System · Respiratory | $300 |
| Zoll Respicardia, Inc. May 3, 2025 | Travel and Lodging remede System · Respiratory · travel to Minneapolis, MN | $90.00 |
| Zoll Respicardia, Inc. Nov 14, 2025 | Travel and Lodging remede System · Respiratory · travel to Dallas, TX | $60.00 |
All 11 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Zoll Respicardia, Inc. Nov 14, 2025 | Speaking at a medical education program remede System · Respiratory | $3,000 |
| Zoll Respicardia, Inc. Nov 14, 2025 | Travel and Lodging remede System · Respiratory · travel to Dallas, TX | $883 |
| Zoll Respicardia, Inc. Nov 14, 2025 | Travel and Lodging remede System · Respiratory · travel to Dallas, TX | $60.00 |
| Zoll Respicardia, Inc. Oct 20, 2025 | Speaking at a medical education program remede System · Respiratory | $3,000 |
| Zoll Respicardia, Inc. Oct 20, 2025 | Consulting Fee remede System · Respiratory | $300 |
| Zoll Respicardia, Inc. Oct 20, 2025 | Travel and Lodging remede System · Respiratory · travel to Chicago, IL | $27.94 |
| Zoll Respicardia, Inc. Oct 1, 2025 | Consulting Fee remede System · Respiratory | $3,000 |
| Zoll Respicardia, Inc. Jun 9, 2025 | Speaking at a medical education program remede System · Respiratory | $3,000 |
| Zoll Respicardia, Inc. May 3, 2025 | Speaking at a medical education program remede System · Respiratory | $4,500 |
| Zoll Respicardia, Inc. May 3, 2025 | Travel and Lodging remede System · Respiratory · travel to Minneapolis, MN | $90.00 |
| Zoll Respicardia, Inc. May 1, 2025 | Travel and Lodging remede System · Respiratory · travel to Minneapolis, MN | $992 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $20,403 in research payments for these studies, mostly to the institutions running them.
- ZOLL Respicardia, Inc. Registry Study
Zoll Respicardia, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.